chartexchange

IBRX Stock Crashes To Near 9-Month Lows On Q3 Earnings Miss – Retail Says No Way To Escape Further Dilution

Stocktwits | Nov 9, 2026 9:36 AM EST

ImmunityBio reported a first topline miss in six quarters after Q3 revenue came in at $48.8 million, sharply below Wall Street’s estimate of $59.2 million, according to Fiscal.ai.

Read original article